Earnings Ahead

SCYX - SCYNEXIS, Inc.

2.77 -0.03 -1.07

  1. Home
  2. Healthcare
  3. SCYX
SCYNEXIS, Inc.

SCYNEXIS, Inc.

About

Profile

Headquarters

Jersey City, New Jersey, United States

Intraday

High
-
Low
-

52-week

High
-
Low
-

SCYX



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • SCYNEXIS GAAP EPS of -$0.30 beats by $0.10, revenue of $1.4M beats by $0.13M
  • SCYNEXIS jumps 92% on licensing deal with GSK for anti-fungal agent
  • Cidara off 27% despite FDA nod amid selloff in antifungal space
  • Deadly fungal infection sweeps across U.S.
  • Scynexis adds 23% most in over two years as Guggenheim says Buy
  • SCYNEXIS wins FDA label expansion for anti-fungal therapy
  • Researchers get $3M NIH grant to study Scynexis' antifungal drug SCY-247
  • SCYNEXIS GAAP EPS of -$0.62 misses by $0.12, revenue of $1.56M misses by $0.5M
  • Scynexis appoints Ivor Macleod as CFO
  • Scynexis announces changes to leadership and strategic direction
  • Scynexis stock rises as Brexafemme sales nearly double Q/Q
  • SCYNEXIS GAAP EPS of -$0.31 beats by $0.28, revenue of $1.32M misses by $0.32M
  • SCYNEXIS Q2 2022 Earnings Preview
  • FDA accepts Scynexis' application to expand label for vaginal yeast infections treatment
  • SCYNEXIS gains after favorable data for antifungal agent in new indication
  • SCYNEXIS GAAP EPS of -$0.17, revenue of $0.7M
  • SCYNEXIS Q1 2022 Earnings Preview
  • SCYNEXIS plunges on pricing $45M in stock and pre-funded warrants offering
  • Scynexis stock falls 17% despite fungal infection drug showing promise in interim data from 2 late-stage studies
  • Scynexis initiates stock offering plan
PEERS
/XLV

XLV

Earnings History

Date EPS / Forecast Revenue / Forecast
November 10, 2021 -0.06 / -0.725 516K / 562.5K
August 16, 2021 -0.22 / -0.5733 - / -
May 17, 2021 -0.18 / -0.5883 12.05M / 2.5M Beat!
March 29, 2021 -3.42 / -0.7286 - / -
November 17, 2020 - / -1.02 - / -
November 6, 2020 0.09 / -0.996 - / -
August 11, 2020 - / -1.13 - / -
May 11, 2020 -0.7 / -0.15 - / -
March 11, 2020 -2.2 / -0.19 - / 20K
November 12, 2019 -1.5 / -0.2 - / 56.25K Beat!
August 7, 2019 -0.16 / -0.18 57K / 65.6K
May 13, 2019 -0.46 / -0.36 64K / 74.43K
March 15, 2019 0.03 / 0.03 77K / 76K Beat!
November 13, 2018 0.01 / -0.16 64K / 69.5K
August 9, 2018 -0.23 / -0.17 64K / 76.11K
May 8, 2018 -0.12 / -0.18 64K / 78.8K
November 6, 2017 -0.31 / -0.34 64.00K / - Beat!
August 14, 2017 -0.27 / -0.34 64.00K / 57.00K Beat!
May 8, 2017 -0.25 / -0.34 64.00K / - Beat!
March 6, 2017 -0.05 / -0.32 64.00K / 66.70K
November 11, 2016 -0.48 / -0.46 64.00K / 60.00K Beat!
August 17, 2016 -0.56 / -0.55 64.00K / 100.0K
Date Price Open High Low Vol Change ER
May 11 1.870 1.950
2.070
1.850
174.22K -5.56%
May 10 1.980 1.960
2.020
1.890
242.62K 0.51%
May 9 1.970 2.220
2.222
1.930
388.58K -12.05%
May 6 2.240 2.410
2.410
2.210
225.78K -7.82%
May 5 2.430 2.610
2.650
2.400
161.94K -6.9%
 
May 4 2.610 2.720
2.720
2.460
253.71K -4.04%
May 3 2.720 2.660
2.760
2.630
236.21K 1.12%
May 2 2.690 2.700
2.730
2.560
192.65K 0.75%
Apr 29 2.670 2.550
2.720
2.510
473.76K 3.49%
Apr 28 2.580 2.430
2.650
2.335
613.94K 11.69%
Apr 27 2.310 2.360
2.360
2.190
414.18K 0.43%
Apr 26 2.300 2.390
2.410
2.270
250.00K -4.17%
Apr 25 2.400 2.310
2.440
2.170
583.14K 3%
Apr 22 2.330 2.560
2.560
2.300
3.13M -25.8%
Apr 21 3.140 3.150
3.200
3.110
314.41K 0.32%
Apr 20 3.130 3.260
3.260
3.120
180.01K -4.28%
Apr 19 3.270 3.220
3.300
3.220
109.85K 0.31%
Apr 18 3.260 3.310
3.310
3.200
196.11K -2.69%
Apr 14 3.350 3.360
3.400
3.260
234.11K -1.47%
Apr 13 3.400 3.420
3.420
3.330
121.86K 0%
Apr 12 3.400 3.410
3.465
3.330
132.22K 0.59%